Atherectomy Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

Atherectomy Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028


The global atherectomy devices market size reached US$ 930 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 1,260 Million by 2028, exhibiting a growth rate (CAGR) of 5.2% during 2022-2028.

Atherectomy devices refer to various minimally invasive (MI) instruments used for peripheral vascular intervention procedures. They are designed to re-establish blood flow in the arteries by drilling, grinding, shaving, sanding and vaporizing plaque, calcifying lesions and excessive cellular material. Some of the commonly used atherectomy devices include direction, orbital, photo-ablative, rotational and support atherectomy devices. The devices consist of a rotating blade inside a tubular catheter attached to a battery-operated motor that spins the cutter and removes the plaque or calcified lesion. As a result, atherectomy devices find extensive applications in hospitals, surgical centers and ambulatory care centers.

The increasing prevalence of peripheral artery disease (PAD), atherosclerosis, diabetes and obesity, along with the rising geriatric population across the globe, represent as the key factors driving the growth of the market. Furthermore, the growing preference for MI atherectomy surgical procedures among both patients and healthcare providers is creating a positive outlook for the market. These devices reduce the risks of infections, cause minimal pain and trauma during the surgery and facilitate faster recovery of the patient. Additionally, various product innovations, such as the development of drug-coated balloons (DCB), are acting as other growth-inducing factors. DCBs are used in place of permanent implants with directional atherectomy and anti-restenosis therapy (DAART) to deliver anti-proliferative drugs and treat lesions with severe calcifications. Other factors, including extensive research and development (R&D) activities, along with improvements in the healthcare infrastructure, are anticipated to drive the market further.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global atherectomy devices market report, along with forecasts at the global, regional and country levels from 2023-2028. Our report has categorized the market based on product, application and end user.

Breakup by Product:

Directional Atherectomy Devices

Orbital Atherectomy Devices

Photo-Ablative Atherectomy Devices

Rotational Atherectomy Devices

Support Devices



Breakup by Application:

Peripheral Vascular

Cardiovascular

Neurovascular



Breakup by End User:

Hospitals

Ambulatory Surgery Centers

Research Laboratories and Academic Institutes



Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa



Competitive Landscape:

The competitive landscape of the industry has also been examined with some of the key players being Abbott Laboratories, Avinger, B. Braun Melsungen AG, Biomerics, Biotronik, Boston Scientific Corporation, C.R. Bard (Becton, Dickinson and Company), Cardinal Health, Koninklijke Philips N.V., Medtronic, Minnetronix Inc., Straub Medical AG (Becton, Dickinson and Company) and Terumo Corporation.

Key Questions Answered in This Report

1. What was the size of the global atherectomy devices market in 2022?

2. What is the expected growth rate of the global atherectomy devices market during 2023-2028?

3. What has been the impact of COVID-19 on the global atherectomy devices market?

4. What are the key factors driving the global atherectomy devices market?

5. What is the breakup of the global atherectomy devices market based on the product?

6. What is the breakup of the global atherectomy devices market based on the application?

7. What is the breakup of the global atherectomy devices market based on the end user?

8. What are the key regions in the global atherectomy devices market?

9. Who are the key players/companies in the global atherectomy devices market?


1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Atherectomy Devices Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product
6.1 Directional Atherectomy Devices
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Orbital Atherectomy Devices
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Photo-Ablative Atherectomy Devices
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Rotational Atherectomy Devices
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Support Devices
6.5.1 Market Trends
6.5.2 Market Forecast
7 Market Breakup by Application
7.1 Peripheral Vascular
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Cardiovascular
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Neurovascular
7.3.1 Market Trends
7.3.2 Market Forecast
8 Market Breakup by End User
8.1 Hospitals
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Ambulatory Surgery Centers
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Research Laboratories and Academic Institutes
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Abbott Laboratories
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Avinger
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.3 B. Braun Melsungen AG
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 Biomerics
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.5 Biotronik
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 Boston Scientific Corporation
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 C.R. Bard (Becton, Dickinson and Company)
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.8 Cardinal Health Inc.
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 Koninklijke Philips N.V.
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
14.3.10 Medtronic
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.11 Minnetronix Inc.
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.12 Straub Medical AG (Becton, Dickinson and Company)
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio
14.3.13 Terumo Corporation
14.3.13.1 Company Overview
14.3.13.2 Product Portfolio
14.3.13.3 Financials
14.3.13.4 SWOT Analysis

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings